NO20025983L - Smertestillende og antiinflammatoriske sammensetninger som inneholder COX-2hemmere - Google Patents
Smertestillende og antiinflammatoriske sammensetninger som inneholder COX-2hemmereInfo
- Publication number
- NO20025983L NO20025983L NO20025983A NO20025983A NO20025983L NO 20025983 L NO20025983 L NO 20025983L NO 20025983 A NO20025983 A NO 20025983A NO 20025983 A NO20025983 A NO 20025983A NO 20025983 L NO20025983 L NO 20025983L
- Authority
- NO
- Norway
- Prior art keywords
- painkillers
- inhibitors
- compositions containing
- inflammatory compositions
- containing cox
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21130700P | 2000-06-13 | 2000-06-13 | |
PCT/US2001/018990 WO2001095898A1 (en) | 2000-06-13 | 2001-06-13 | Analgesic and anti-inflammatory compositions containing cox-2 inhibitors |
Publications (3)
Publication Number | Publication Date |
---|---|
NO20025983D0 NO20025983D0 (no) | 2002-12-12 |
NO20025983L true NO20025983L (no) | 2003-02-10 |
NO331092B1 NO331092B1 (no) | 2011-10-03 |
Family
ID=22786362
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20025983A NO331092B1 (no) | 2000-06-13 | 2002-12-12 | Sammensetning bestaende av celecoxib og ibuprofen. |
Country Status (23)
Country | Link |
---|---|
US (2) | US6924303B2 (no) |
EP (1) | EP1296665B1 (no) |
JP (1) | JP5579958B2 (no) |
KR (1) | KR20030019422A (no) |
CN (1) | CN100588395C (no) |
AT (1) | ATE511844T1 (no) |
AU (2) | AU2001268377B2 (no) |
BR (1) | BR0111767A (no) |
CA (1) | CA2411960C (no) |
DK (1) | DK1296665T3 (no) |
EA (2) | EA011309B1 (no) |
ES (1) | ES2365387T3 (no) |
HK (1) | HK1059378A1 (no) |
HU (1) | HU229440B1 (no) |
IL (2) | IL153303A0 (no) |
MX (1) | MXPA02012344A (no) |
NO (1) | NO331092B1 (no) |
NZ (1) | NZ522957A (no) |
PL (1) | PL206268B1 (no) |
PT (1) | PT1296665E (no) |
RU (1) | RU2003100874A (no) |
WO (1) | WO2001095898A1 (no) |
ZA (1) | ZA200209944B (no) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0111767A (pt) | 2000-06-13 | 2003-07-08 | Wyeth Corp | Composições analgésicas e anti-inflamatórias contendo inibidores de cox-2, seu uso e método para potencializar um composto analgésico |
CN100418533C (zh) * | 2002-02-19 | 2008-09-17 | 阿德科克因格拉姆有限公司 | 环加氧酶-2抑制剂和阿片剂的药物组合体 |
WO2004056305A2 (en) * | 2002-12-18 | 2004-07-08 | Algorx | Administration of capsaicinoids |
TW200600086A (en) * | 2004-06-05 | 2006-01-01 | Astrazeneca Ab | Chemical compound |
US20060281775A1 (en) | 2005-06-14 | 2006-12-14 | Applied Pharmacy Services, Inc. | Two-component pharmaceutical composition for the treatment of pain |
US8580855B2 (en) | 2006-10-20 | 2013-11-12 | Mcneil-Ppc, Inc. | Acetaminophen / ibuprofen combinations and method for their use |
TR200904862A1 (tr) * | 2009-05-29 | 2010-12-21 | Sanovel İlaç San. Ve Ti̇c. A.Ş. | Sukraloz formülasyonu ve üretim prosesi |
EP3463340A2 (en) * | 2016-05-27 | 2019-04-10 | Dr. Reddy's Laboratories Ltd. | Oral composition of celecoxib for treatment of pain |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5331000A (en) * | 1992-03-09 | 1994-07-19 | Sepracor Inc. | Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen |
US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
CA2276945C (en) * | 1993-11-30 | 2006-08-01 | G.D. Searle & Co. | Tricyclic-substituted pyrazolyl benzenesulfonamides and pharmaceutical compositions thereof |
EE03746B1 (et) | 1996-05-17 | 2002-06-17 | Merck & Co., Inc. | Farmatseutiline kompositsioon tsüklooksügenaas-2 vahendatud haiguste raviks, 3-fenüül-4-(4-(metüülsulfonüül) fenüül)-2-(5H)-furanooni kasutamine ja ühikuline oraalne doseerimisvorm |
PL187848B1 (pl) | 1996-07-18 | 2004-10-29 | Merck Frosst Canada Inc | Podstawione pirydyny, kompozycja farmaceutyczna, podstawione pirydyny jako selektywne inhibitory cyklooksygenazy-2 oraz zastosowanie podstawionych pirydyn |
US6160020A (en) * | 1996-12-20 | 2000-12-12 | Mcneill-Ppc, Inc. | Alkali metal and alkaline-earth metal salts of acetaminophen |
RU2182016C2 (ru) * | 1997-03-20 | 2002-05-10 | Панацея Биотек Лтд. | Спазмолитическая композиция, способ получения спазмолитической композиции |
EP0868915A1 (en) | 1997-04-02 | 1998-10-07 | Panacea Biotec Limited | An anti-spasmodic and antiinflammatory composition containing a NSAID, pentifenone and fenpiverinium |
DZ2479A1 (fr) | 1997-05-05 | 2003-02-01 | Pfizer | Composés inhibiteurs sélectifs de cox-2 anti-inflammatoires et compositions pharmaceutiques les contenant. |
RS49982B (sr) * | 1997-09-17 | 2008-09-29 | Euro-Celtique S.A., | Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2 |
FR2770131A1 (fr) * | 1997-10-27 | 1999-04-30 | Union Pharma Scient Appl | Nouvelle association pharmaceutique a activite analgesique |
DE60007267T2 (de) | 1999-04-14 | 2004-09-16 | Pacific Corp. | 4,5-diaryl-3(2h)-furanon derivate als cyclooxygenase-2 inhibitoren |
US6524623B1 (en) * | 1999-11-12 | 2003-02-25 | Milton Hodosh | Therapeutic compositions and methods of use thereof |
DE60027464T2 (de) * | 1999-12-22 | 2006-08-31 | Pharmacia Corp. | Arzneizubereitungen mit zwei verschiedenen freisetzungsraten enthaltend einen cyclooxygenase-2 hemmer |
US6306842B1 (en) * | 2000-06-02 | 2001-10-23 | Medinox, Inc. | Protected forms of a combination of pharmacologically active agents and uses therefor |
BR0111767A (pt) * | 2000-06-13 | 2003-07-08 | Wyeth Corp | Composições analgésicas e anti-inflamatórias contendo inibidores de cox-2, seu uso e método para potencializar um composto analgésico |
-
2001
- 2001-06-13 BR BR0111767-0A patent/BR0111767A/pt not_active Application Discontinuation
- 2001-06-13 EA EA200300692A patent/EA011309B1/ru not_active IP Right Cessation
- 2001-06-13 JP JP2002510077A patent/JP5579958B2/ja not_active Expired - Lifetime
- 2001-06-13 EA EA200802070A patent/EA200802070A1/ru unknown
- 2001-06-13 HU HU0301348A patent/HU229440B1/hu unknown
- 2001-06-13 KR KR1020027016906A patent/KR20030019422A/ko not_active Application Discontinuation
- 2001-06-13 AT AT01946309T patent/ATE511844T1/de active
- 2001-06-13 EP EP01946309A patent/EP1296665B1/en not_active Expired - Lifetime
- 2001-06-13 MX MXPA02012344A patent/MXPA02012344A/es active IP Right Grant
- 2001-06-13 AU AU2001268377A patent/AU2001268377B2/en not_active Expired
- 2001-06-13 NZ NZ522957A patent/NZ522957A/en not_active IP Right Cessation
- 2001-06-13 AU AU6837701A patent/AU6837701A/xx active Pending
- 2001-06-13 CN CN01813180A patent/CN100588395C/zh not_active Expired - Lifetime
- 2001-06-13 US US10/297,897 patent/US6924303B2/en not_active Expired - Lifetime
- 2001-06-13 PL PL360469A patent/PL206268B1/pl unknown
- 2001-06-13 RU RU2003100874/15A patent/RU2003100874A/ru not_active Application Discontinuation
- 2001-06-13 WO PCT/US2001/018990 patent/WO2001095898A1/en active IP Right Grant
- 2001-06-13 IL IL15330301A patent/IL153303A0/xx unknown
- 2001-06-13 ES ES01946309T patent/ES2365387T3/es not_active Expired - Lifetime
- 2001-06-13 CA CA2411960A patent/CA2411960C/en not_active Expired - Lifetime
- 2001-06-13 PT PT01946309T patent/PT1296665E/pt unknown
- 2001-06-13 DK DK01946309.0T patent/DK1296665T3/da active
-
2002
- 2002-12-05 IL IL153303A patent/IL153303A/en active IP Right Grant
- 2002-12-09 ZA ZA200209944A patent/ZA200209944B/xx unknown
- 2002-12-12 NO NO20025983A patent/NO331092B1/no not_active IP Right Cessation
-
2004
- 2004-03-12 HK HK04101837.1A patent/HK1059378A1/xx not_active IP Right Cessation
- 2004-12-13 US US11/012,021 patent/US7754753B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1108823T1 (el) | Παραγωγα 2-υδροξυ-3-ετεροαρυλινδολης ως αναστολεις της gsk3 | |
EA200301018A1 (ru) | Доставляемая перорально фармацевтическая композиция, включающая активное соединение, содержащее аминосульфонильную группу (ингибитор cox-2), полиэтиленгликоль и улавливающий свободные радикалы антиоксидант | |
DK1509232T3 (da) | Kombination af en NMDA-antagonist og acetylcholin-esterase inhibitorer til behandling af Alzheimers sygdom | |
BR9907300A (pt) | Inibidores do fator xa oxoaza-heterociclila substituìdos | |
ATE303178T1 (de) | Acc-hemmer | |
BRPI0409068A (pt) | composições farmacêuticas para inibidores de protease viral de hepatite c. | |
UA91204C2 (ru) | Композиция для преодоления опосредствованной бета-лактамазой резистентности к антибиотикам с использованием ингибитора бета-лактамазы, предназначенная для инъекции | |
HUP0301660A2 (hu) | Neutrális endropeptidáz inhibitor (NEPI) vegyületek alkalmazása férfi szexuális mżködési zavar kezelésére és az azokat tartalmazó gyógyszerkészítmények | |
CY1107473T1 (el) | Ενα παραγωγο pyridine-n-oxide, και διαδικασια για τη μετατροπη του σε αποτελεσματικες φαρμακευτικες συνθεσεις | |
EE200300168A (et) | Tripeptidüülpeptidaasi inhibiitorid, nende valmistamine ja kasutamine ravimina ning neid sisaldav farmatseutiline kompositsioon | |
DK1678162T3 (da) | P-glycoprotein-inhibitor, fremgangsmåde til fremstilling heraf og farmaceutisk sammensætning omfattende denne | |
NO20025983D0 (no) | Smertestillende og antiinflammatoriske sammensetninger som inneholder COX-2hemmere | |
PA8586801A1 (es) | Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso | |
BR0306928A (pt) | Composições farmacêuticas estáveis compreendendo inibidores de enzimas conversoras de angiotensina (ace) | |
BR0213181A (pt) | Combinações de inibidor de cox-2 | |
ATE193526T1 (de) | Alkylierte styrole als prodrugs zu cox-2- inhibitoren | |
ATE548350T1 (de) | N-arylpiperidin-substituierte biphenylcarbonsäureamide als inhibitoren von apolipoprotein b | |
MXPA02010828A (es) | Composicion farmaceutica en capsulas que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor. | |
HUP0303341A2 (hu) | Monoamin-felvétel inhibitora és ezt tartalmazó gyógyszerkészítmények | |
PT1250125E (pt) | Composicoes farmaceuticas contendo terbinafina | |
EA200601015A1 (ru) | Пероральные композиции дезоксипеганина и их применение | |
AU2001244999A1 (en) | Naphthamide neurokinin antagonists for use as medicaments | |
IS6577A (is) | Læknisfræðilega gagnleg ný sölt CCK tálma, aðferðtil að búa þau til og lyfjablöndur sem innihalda þau | |
DK1648413T3 (da) | Farmaceutiske præparater af kortvirkende sedativt sövndyssende middel | |
WO2001072735A3 (en) | Benzopyranes useful as tnf alpha inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |